Our portfolio company Ochre Bio’s CEO Jack O’Meara spoke on The Healthtech Podcast, hosted by Dr. James Somauroo, where he discussed:
- How and why we utilise human livers outside the body for developing new liver medicines
- Why the FDA no longer mandates animal testing ahead of clinical trials what that means for companies like Ochre Bio
- The economic benefits of a human-centric approach to therapy development
